Cargando…
难治/复发重型再生障碍性贫血23例二次免疫抑制治疗临床分析
OBJECTIVE: This study aims to evaluate the efficacy and safety of secondary immunosuppressive therapy (IST) in refractory or relapsed severe aplastic anemia. METHODS: The hematologic response and safety of 23 patients with refractory or relapsed SAA treated with secondary IST (including ATG/ALG + cy...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525170/ https://www.ncbi.nlm.nih.gov/pubmed/32942820 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.08.008 |
Ejemplares similares
-
我如何治疗难治性重型再生障碍性贫血
Publicado: (2020) -
重型再生障碍性贫血免疫抑制治疗疗效预测及治疗展望
Publicado: (2020) -
免疫抑制治疗后合并血流感染的重型再生障碍性贫血患者临床特征及预后分析
Publicado: (2016) -
重型再生障碍性贫血免疫抑制治疗迟发血液学反应研究
Publicado: (2016) -
异基因造血干细胞移植治疗重型再生障碍性贫血71例临床分析
Publicado: (2016)